Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA 15213.
The Center for Nucleic Acids Science and Technology, Carnegie Mellon University, Pittsburgh, PA 15213.
Proc Natl Acad Sci U S A. 2021 Jan 12;118(2). doi: 10.1073/pnas.2020241118.
Exosomes are emerging as ideal drug delivery vehicles due to their biological origin and ability to transfer cargo between cells. However, rapid clearance of exogenous exosomes from the circulation as well as aggregation of exosomes and shedding of surface proteins during storage limit their clinical translation. Here, we demonstrate highly controlled and reversible functionalization of exosome surfaces with well-defined polymers that modulate the exosome's physiochemical and pharmacokinetic properties. Using cholesterol-modified DNA tethers and complementary DNA block copolymers, exosome surfaces were engineered with different biocompatible polymers. Additionally, polymers were directly grafted from the exosome surface using biocompatible photo-mediated atom transfer radical polymerization (ATRP). These exosome polymer hybrids (EPHs) exhibited enhanced stability under various storage conditions and in the presence of proteolytic enzymes. Tuning of the polymer length and surface loading allowed precise control over exosome surface interactions, cellular uptake, and preserved bioactivity. EPHs show fourfold higher blood circulation time without altering tissue distribution profiles. Our results highlight the potential of precise nanoengineering of exosomes toward developing advanced drug and therapeutic delivery systems using modern ATRP methods.
外泌体作为理想的药物传递载体而备受关注,这是因为它们具有生物起源,并能够在细胞间传递货物。然而,外泌体在血液循环中被迅速清除,以及在储存过程中外泌体的聚集和表面蛋白的脱落,限制了它们的临床转化。在这里,我们展示了对外泌体表面进行高度可控和可逆功能化的方法,使用的是具有明确聚合物,这些聚合物可调节外泌体的物理化学和药代动力学特性。使用胆固醇修饰的 DNA 系绳和互补的 DNA 嵌段共聚物,我们在外泌体表面设计了具有不同生物相容性的聚合物。此外,还可以使用生物相容性的光介导原子转移自由基聚合(ATRP)直接从外泌体表面接枝聚合物。这些外泌体聚合物杂化物(EPHs)在各种储存条件下和存在蛋白水解酶的情况下表现出增强的稳定性。通过调整聚合物的长度和表面负载,可以精确控制外泌体表面相互作用、细胞摄取和保持生物活性。EPHs 的血液循环时间延长了四倍,而不会改变组织分布谱。我们的结果强调了使用现代 ATRP 方法精确纳米工程外泌体以开发先进药物和治疗性递药系统的潜力。